PROTOCOL REVIEW COMMITTEE

这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。次级项目的主要支助 而子项目的主要调查员可能是由其他来源提供的， 包括其它NIH来源。 为子项目列出的总成本可能 表示子项目使用的中心基础设施的估计数量， 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 方案审查委员会的目的是与IRB同时审查RR中涉及人类受试者的任何项目。 UT西南IRB的批准并不保证获得PRC的批准。 PRC审查的重点是受试者的安全性和可行性。委员会的第二个目的是征求用户对经常资源内程序的意见。 委员会成员在物理学博士和工程师以及医学博士之间大致平衡。 委员会成员如下：Jeannie Davis、Hanzhang Lu、Ivan Dimitrov、克雷格马洛伊、John哈特、Bart Rypma、Beverly Huet、Andrew Kozel、Hanzhang Lu和Dana马修斯。 委员会会议1每月2次，视审查和其他问题的需要而定。 新的申请被分配给委员会的一名初级和二级审查员进行初步审查。 在委员会会议上，主要审查员将向委员会提交拟议研究的摘要，并建议是否批准。 申请被推迟，有条件批准，或最终批准。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The purpose of the Protocol Review Committee is to provide a review, in parallel with the IRB, of any projects involving human subjects in the RR. Approval by the UT Southwestern IRB does not guarantee approval by the PRC. The focus of the PRC review is safety for the subject and feasibility. A secondary purpose of the Committee is to seek input on procedures within the RR from users. Committee membership is approximately balanced between PhD physicis and engineers, and MDs. Members of the Committee are: Jeannie Davis, Hanzhang Lu, Ivan Dimitrov, Craig Malloy, John Hart, Bart Rypma, Beverly Huet, Andrew Kozel, Hanzhang Lu, and Dana Mathews. The Committee meets 12 times per month, depending on the need for reviews and other issues. A new application is assigned to a primary and secondary reviewer on the Committee for initial review. At the Committee meeting, the primary reviewer will present a summary of the proposed research to the Committee with a recommendation whether to approve. Applications are deferred, approved with stipulations, or given final approval.